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ABSTRACT
Purpose: To study the influence of glutamine on functional and morphological changes of liver in the extrahepatic biliary obstruction
through an experimental model in rats. Methods: Seventy Wistar rats were divided into four groups: control (group C) fictitious
operation, (group FO), submitted to laparotomy with handling of bile ducts, but without hepatic duct ligation, (group EBO) submitted
to laparotomy and hepatic duct ligation, one of them submitted to supplementation with glutamine 2% (group G). The control group
consisted of 6 animals. The animals from groups FO, EBO and G were divided into three groups consisting of 6 animals each, being
sacrificed at 7, 14 and 21 days after operation, respectively. Blood samples were collected for biochemical analysis and a fragment of
liver tissue was collected from the middle lobe for histological analysis. Results: Both for biochemical analysis (BT, aspartate and
alanine aminotransferase AST, ALT and alkaline phosphatase FAL) and for histopathological changes (fibrosis, portal inflammation,
parenchymal inflammation, hepatocytic changes and duct proliferation), no statistical difference between groups submitted to
extrahepatic biliary obstruction (EBO) with and without treatment with glutamine (G) was observed. Conclusion: Glutamine
supplementation did not alter the prognosis of liver enzymes and histopathological changes in animals submitted to extrahepatic
biliary obstruction.
Key words: Cholestasis, Extrahepatic. Glutamine. Liver. Rats.
RESUMO
Objetivo: Estudar a influência da glutamina em alterações funcionais e morfológicas do fígado na obstrução biliar extra-hepática por
meio de um modelo experimental desenvolvido em ratos. Métodos: Setenta ratos Wistar distribuídos em quatro grupos: controle (grupo
C); operação fictícia (grupo OF), submetido à laparotomia com manuseio das vias biliares, mas sem ligadura do ducto hepático; (grupo
OBE), submetido à laparotomia exploradora e ligadura do ducto hepático, sendo um deles submetido à suplementação com glutamina a
2% (grupo G). O grupo controle era composto por seis animais. Os animais dos grupos OF, OBE e G foram divididos em três grupos
compostos por seis animais cada e que foram sacrificados no 7°, 14° e 21° dias após a operação, respectivamente. Foi colhido sangue
para análise bioquímica e um fragmento de tecido hepático do lobo médio para estudo histológico. Resultados: Tanto em relação à
analise bioquímica (BT, aspartate and alanine aminotransferase AST, ALT e FAL) quanto em relação às alterações histopatológicas
(fibrose, inflamação portal, inflamação parenquimatosa, alterações hepatocíticas e proliferação de ducto), não houve diferença estatística
entre os grupos submetido a obstrução biliar extra-hepática sem (OBE) e com tratamento com glutamina (G). Conclusão: A suplementação
com glutamina não alterou o prognóstico em relação às enzimas hepáticas e alterações histopatológicas nos animais submetidos à
obstrução biliar extra-hepática.
Descritores: Colestase Extra-Hepática. Glutamina. Fígado. Ratos.
1Research performed at Experimental Laboratory of Surgery, School of Medicine, University of Brasília (UnB) and Pathology Anatomy Service,
Brasilia University Hospital (HUB), Brazil.
Introduction
Extrahepatic biliary obstruction is associated with high
postoperative morbidity and mortality rates1. Whatever the origin,
it is associated with morphological and functional injury of the
liver2-4, and a lower immune resistance, factors that contribute
significantly to various postoperative complications such as
sepsis, bleeding disorders and kidney failure1. The following are
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among the main changes: increased serum levels of direct bilirubin,
resulting from canalicular retro-diffusion; increased levels of
alkaline phosphatase (ALP) and gamma-glutamyltranspeptidase
(gamma-GT), while the aspartate and alanine aminotransferase
levels (AST and ALT) can be normal or high, all due to the
hepatocyte membrane injury secondary to the biliary stasis2,3,5.
Morphologically, dilation with duct proliferation and periportal
hepatitis and septal fibrosis apoptosis bridges and necrosis can
be both observed, which may lead to cirrhosis2. The loss of the
hepatic structure also leads to progressive change of the function
of this organ, which can be observed by the elevation of indirect
bilirubin, due to its non conjugation, and by the change in the
synthesis of serum proteins such as albumin and coagulation
factors2. Besides the bile stasis, other possible injury mechanisms
include the production of free radicals2,4.
Several experiments have shown the role of glutamine as
protective agent against these free radicals6,7. Supplementation
with glutamine and alanine-glutamine dipeptide was effective
in increasing the hepatic synthesis of antioxidant enzymes,
protecting the tissue from the action of free radicals in rats submitted
to total parenteral nutrition6. In a hepatic ischemia-reperfusion
injury model, treatment with alanine-glutamine dipeptide seemed
to preserve the antioxidant capacity, to protect the structure and
mitochondrial function and to decrease the production of free
radicals8. Another study showed protection against liver injury
induced by hemorrhagic shock in rats by the best use of cellular
energy, decreased apoptosis and improved survival rate9. The
antioxidant function in other systems has also been confirmed
in an experiment where the administration of glutamine improved
vascular reactivity by decreasing the production of cytokines and
free radicals involved in a septic shock model in rats7,10. Other roles
played by this substance include the autophagic proteolysis
regulation, synthesis of glycogen and fatty acids, insulin signaling,
protection against apoptosis, especially in the canalicular excretion
of bile acids11, besides presenting a trophic potential on hepatocytes.
The metabolism of glutamine in the liver is involved in the systemic
detoxification by ammonia and blood pH regulation11.
The amino acid glutamine appears to have anabolic
properties for various organic systems. Its supplementation has
resulted in beneficial clinical outcomes12. Many authors have
postulated that glutamine can prevent or reduce the total bilirubin
values. However, several experimental studies have reported
conflicting results, which were attributed to the animal models
used13. A study in rats submitted to extrahepatic biliary obstruction
tested enteral glutamine supplementation and showed BT and
gamma GT levels significantly lower and TGP levels significantly
higher in the group receiving glutamine supplementation14.
However, there are few studies on the effect of glutamine
on extrahepatic cholestasis models. A study on double ligation,
followed by resection between points, decreased the apoptosis
of hepatocytes and bile duct proliferation in rats after 3 days of
ligation, not showing the same effect 7 days after operation in groups
of 5 animals5. Another study, with double ligation followed by
resection between ligations resulted in decreased duct proliferation
in relation to the group without glutamine supplementation15.
Several studies in literature have been evaluating the
effects of enteral and parenteral glutamine supplementation.
Studies in critically ill patients and surgical patients showed that
the parenteral administration was more effective in increasing
plasma concentrations in relation to oral administration16,17.
Another study in mice showed that when L-alanyl-L-glutamine was
enterally administrated, there was a more significant increase for
the synthesis of L-citrulline and L-arginine in relation to the
parenteral administration18. Since results of studies on enteral or
parenteral glutamine supplementation proved to be conflicting due
to possible differences in metabolism depending on the type of
administration, it is necessary to conduct a research involving the
clinical benefit of enteral glutamine.
The project goal was to evaluate the influence of enteral
glutamine on enzymatic and histological hepatic alterations of rats
submitted to extrahepatic biliary obstruction, taking into account
its protective role against damages caused by the production of
free radical from cholestasis.
Methods
This study was developed at the Laboratory of
Experimental Surgery, School Medicine, of University of Brasilia
and Pathology Anatomy Service – Brasilia University Hospital.
The study was carried out within the guidelines of the
Brazilian College of Animal Experiments (COBEA) and was
submitted and approved by the Ethics Committee in Animal
Research of the Biological Sciences Institute, University of Brasilia.
All surgical procedures were performed with Xylazine 2%
(10mg/kg) and ketamine 10% (100mg/kg) intramuscularly applied.
Then, abdominal trichotomy, cleansing with iodine alcohol and
laparotomy were performed.
The animals from group of Fictitious Operation (FO) were
submitted to handling of bile ducts.
The animals from groups Extrahepatic Biliary Obstruction
(EBO) and G were submitted to ligature of the hepatic duct.
Animals and experimental design
Seventy male Wistar rats weighing between 250 and 350
g and 90 days of age were divided into four groups:
1. Group C (Control): 6 animals for control;
2. Group FO (fictitious operation): 18 rats submitted to
laparotomy and handling of the bile duct without bile duct ligation
(fictitious operation);
3. Group EBO (Extrahepatic Biliary Obstruction): 18
animals submitted to EBO induction through the folding of the
hepatic duct; Ref
4. Group G (treated with glutamine): 6 animals submitted
to laparotomy with bile duct ligation and treated with glutamine
2% (aqueous solution).
The animals from groups FO, EBO and G were divided
into three groups consisting of 6 animals each, submitted to
euthanasia at 7, 14 and 21 days after operation, respectively.
During the study period, the animals were kept in cages
for 5 animals. The animals were kept at room temperature and were
submitted to a light / dark cycle of 12 hours each. All animals
received rat chow and water ad libitum and, in the case of animals
from the treated group (group G), the water contained 2% of glutamine.
Blood samples and liver tissue fragments were collected
immediately before the euthanasia of each rat. Measurements of
bilirubin, aminotransferase and alkaline phosphatase were made,
as well as histopathological analysis of liver fragments.
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Histopathological study
Liver tissue samples were fixed in formaldehyde solution
10%, embedded in paraffin and stained with hematoxylin-eosin.
Histopathological study was performed by a pathologist who was
unaware of the conditions and analyzed the presence of fibrosis or
portal inflammation and parenchymal inflammation. All parameters
were given a score from 0 to 4, following this pattern: “0” no change
“1” mild changes, “2” moderate changes “3” marked changes and
“4” very substantial changes.
Moreover, nuclear changes, edema, reticular degeneration
and necrosis of hepatocytes were evaluated using the following
scores: “0” no change “1” nuclear changes, “2” hydropic
degeneration, “3” reticular degeneration and apoptosis and “4”
confluent necrosis, thrombi, biliary lakes and cholestasis receiving
the following score: “0” zero, “1” intrahepatic cholestasis, “2”
intra canalicular cholestasis, “3” thrombosis and “4” lakes, and
duct proliferation receiving the following score: “0” zero, “1” mild,
“2” moderate, “3” marked and “4” very severe.
Statistical analysis
The results were analyzed through the Kruskal-Wallis test
followed by Dunn’s method for comparison between groups with
significance of 5% (p <0.05) for all parameters.
Results
All animals from EBO and G groups evolved with signs
and symptoms of cholestasis.
Both for biochemical analysis (BT, TGO, TGP and FAL)
and histopathological changes (fibrosis, portal inflammation,
parenchymal inflammation, hepatocystic changes and duct
proliferation), there was no significant difference between the
EBO groups treated with glutamine for 7 (G7), 14 (G14) and 21
days (G21) compared to groups submitted to EBO for 7 (EBO 7),
14 (EBO 14) and 21 days (EBO 21). (Table 1 to 6) (Figure 1 to 4).
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
1 
0,5 
0 
1,5 
2,5 
0 
2 
1 
0 
0 
0 
0 
0 
1 
1 
0 
1 
0 
0 
0 
1 
2 
0 
2 
3 
1 
3 
3 
TABLE 1 - Median, minimum and maximum values of
fibrosis score in the groups Control (C), Fictitious Operation
(FO), Extrahepatic Biliary Obstruction (EBO) and Treated
with Glutamin (G) for 7, 14 and 21 days
Kruskal-Wallis test; p< 0.0001
TABLE 2 - Median, minimum and maximum values of
portal inflammation score in the groups Control (C),
Fictitious Operation (FO), Extrahepatic Biliary Obstruction
(EBO) and Treated with Glutamin (G) for 7, 14 and 21 days
Kruskal-Wallis test; p< 0.0001
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
1,5 
1 
0 
2 
1 
0 
2 
1 
0 
0 
0 
0 
0 
1 
1 
0 
2 
0 
0 
1 
3 
3 
0 
2 
2 
1 
3 
1 
TABLE 3 - Median, minimum and maximum values of
parenchymal inflammation score in the groups Control (C),
Fictitious Operation (FO), Extrahepatic Biliary Obstruction
(EBO) and Treated with Glutamin (G) for 7, 14 and 21 days
Kruskal-Wallis test; p< 0.0001
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
1 
2 
1 
2 
1,5 
1 
2,5 
1 
0 
0 
0 
1 
0 
1 
1 
0 
1 
0 
0 
0 
2 
2 
1 
2 
3 
1 
3 
1 
TABLE 4 - Median, minimum and maximum values of
hepatocytic changes score in the groups Control (C),
Fictitious Operation (FO), Extrahepatic Biliary Obstruction
(EBO) and Treated with Glutamin (G) for 7, 14 and 21 days
Kruskal-Wallis test; p< 0.0001
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
2 
2 
0 
2,5 
3 
1 
3 
3 
0 
0 
1 
2 
0 
2 
2 
1 
3 
3 
0 
0 
4 
3 
1 
3 
4 
1 
3 
3 
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TABLE 5- Median, minimum and maximum values of
thrombi, biliary lakes and cholestasis scores in the groups
Control (C), Fictitious Operation (FO), Extrahepatic Biliary
Obstruction (EBO) and Treated with Glutamin (G) for 7, 14
and 21 days
Kruskal-Wallis test; p< 0.0001
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
2 
0 
1 
0 
0 
0 
0 
TABLE 6 - Median, minimum and maximum values of duct
proliferation score in the groups Control (C), Fictitious
Operation (FO), Extrahepatic Biliary Obstruction (EBO) and
Treated with Glutamin (G) for 7, 14 and 21 days
Groups Median Min Max 
C 
FO7 
EBO7 
G7 
FO14 
EBO14 
G14 
FO21 
EBO21 
G21 
0 
0 
1,5 
2 
0 
2,5 
3 
0 
4 
3 
0 
0 
0 
1 
0 
2 
3 
0 
2 
2 
0 
0 
2 
3 
0 
3 
4 
0 
4 
4 
Kruskal-Wallis test; p< 0.0001
FIGURE 1 - Total bilirubin serum levels in the groups Control
(C), Fictitious Operation (FO), Extrahepatic Biliary Obstruction
(EBO) and Treated with Glutamin (G) for 7, 14 and 21 days
FIGURE 2 - Aspartate aminotransferase (AST) serum levels in
the groups Control (C), Fictitious Operation (FO), Extrahepatic
Biliary Obstruction (EBO) and Treated with Glutamin (G) for 7,
14 and 21 days
FIGURE 3 - Alanine aminotransferase (ALT) serum levels in
the groups Control (C), Fictitious Operation (FO), Extrahepatic
Biliary Obstruction (EBO) and Treated with Glutamin (G) for 7,
14 and 21 days
FIGURE 4 - Alkaline phosphatase (FAL) serum levels in the
groups Control (C), Fictitious Operation (FO), Extrahepatic
Biliary Obstruction (EBO) and Treated with Glutamin (G) for 7,
14 and 21 days
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Discussion
Obstructive jaundice is a frequent manifestation of
malignant or benign diseases of extrahepatic biliary ducts with
high morbidity and postoperative mortality rates1,19. Patients with
jaundice usually undergo various invasive diagnostic and
therapeutic procedures, which is associated with these high rates
of complications and deaths. The main reported complications
are sepsis, hemorrhage, kidney disorders, hypersensitivity to
endotoxin, among others19,20.
Several experimental and clinical studies have examined
the impact of glutamine supplementation in several disease states.
In humans, glutamine has been enterally administered in doses
ranging from 20 to 30 g / day and parenterally from 12 to 40 g /
day, in conditions such as post-cholecystectomy, post trauma,
septic complications and after bone marrow transplantation. All
these studies showed an improvement in nitrogen balance and
muscle protein balance, also showing that the risk of patients
developing infectious complications after surgery or trauma could
be reduced. However, all these studies failed to demonstrate
reduction in mortality rate and length of hospital stay15.
Our study, using hepatic duct ligation as a model of
extrahepatic cholestasis, allowed all the changes due to cholestasis
both in groups with and without treatment with glutamine as in its
subgroups of 7, 14 and 21 days.
Many authors have postulated that glutamine can prevent
or reduce the total bilirubin values. However, several experimental
studies have documented conflicting results, which were attributed
to the animal models used13. In our study, as for the serum levels of
BT, TGO, TGP and FAL; an increase in these values was observed
for groups submitted to extrahepatic biliary obstruction with and
without treatment with glutamine compared to control and fictitious
operation groups; however, no statistical difference between group
submitted to obstruction treated with glutamine and the group only
submitted to obstruction was observed. Another study, testing
the enteral glutamine supplementation (1mg/kg/d) in rats
submitted to 7 days of extrahepatic biliary obstruction with double
ligation followed by resection between ligations, showed serum
BT and Gamma GT levels significantly lower and serum TGP
levels significantly higher in the group receiving glutamine
supplementation14.
In our study, the histopathological analysis of fibrosis,
portal inflammation, parenchymal inflammation, hepatocytic
changes and duct proliferation showed signs of hepatitis and
factors related to biliary obstruction in all individuals from groups
submitted to extrahepatic biliary obstruction, with and without
treatment with glutamine compared to control and fictitious
operation groups; however, no statistical difference between
group submitted to obstruction treated with glutamine and group
submitted to obstruction only was observed. Regarding the
presence of thrombi, biliary lakes and cholestasis, no statistical
difference between groups was observed. A study with groups of
5 animals involving double ligation followed by resection between
points showed that the administration of glutamine, by means of
gavage (0.2 g / kg of body weight once daily), decreased the
hepatocyte apoptosis and bile duct proliferation in rats after 3 days
of ligation, not showing the same effect 7 days after operation15.
Another study, with double ligation followed by resection, with
groups of 15 animals showed that glutamine 3% administration
ad libitum resulted in decreased duct proliferation in the group
without glutamine supplementation15.
Conclusion
Through the results obtained in this study, glutamine
orally administered did not improve the parameters related to
liver enzymes and histological changes due to biliary obstruction
after 7, 14 and 21 days of treatment.
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